8
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Tendencia de la mortalidad por enfermedades intersticiales en México, período 2000-2010 Translated title: Mortality trends of interstitial lung disease in Mexico, 2000-2010

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Antecedentes: Son escasos los estudios epidemiológicos que analizan las causas de muerte por enfermedades pulmonares intersticiales desde el punto de vista poblacional. Objetivo: Analizar la tendencia de la tasa de mortalidad estandarizada por edad, y las muertes anuales específicas por grupo de edad y sexo por enfermedades pulmonares intersticiales en México durante el período 2000-2010. Métodos: A partir de los datos oficiales del número de muertes por causa (Instituto Nacional de Estadística y Geografía) y de los datos de población de la CONAPO, se calculó la tasa de mortalidad estandarizada por edad para hombres y para mujeres mediante el método directo. También fueron calculadas las tasas de mortalidad por enfermedades intersticiales en dos grupos de edad, de 45-64 años y de 65 y más años para cada uno de los sexos. Los grupos de la Clasificación Internacional de las Enfermedades analizados fueron J60-J80, J82-J84 y J99.1. Resultados: Se registraron 22,600 defunciones codificadas por enfermedades intersticiales pulmonares del total de 5,420,059 muertes ocurridas durante el período de 2000-2010 (0.4%). El código CIE-10 con mayor porcentaje de muertes fue el J84 que correspondió a "otras enfermedades pulmonares intersticiales" con el 80.2% de las muertes durante el período (18,127/22,600). Este grupo incluye a las enfermedades reumáticas y autoinmunes que presentan involucro pulmonar. En la mortalidad estandarizada por edad en ambos sexos, se observó un incremento sostenido en la mortalidad por enfermedades intersticiales pulmonares durante todo el período; sin embargo, los hombres presentaron tasas más altas. La descripción de las tasas anuales de mortalidad específicas por grupo de edad y sexo mostraron un incremento sostenido de las tasas durante todo el período en ambos sexos en la población de 65 y más años. Conclusión: Se muestra la relevancia de las enfermedades intersticiales como causa de muerte en México. En los próximos años se requerirán recursos adicionales para la atención de estas enfermedades.

          Translated abstract

          Background: Worldwide almost no epidemiologic data are available on the mortality of interstitial lung diseases in the general population. Its epidemiology in Mexico has not been well characterized. Objectives: We aimed to analyze the trends in mortality age-standardized by interstitial lung diseases from 2000 to 2010 in Mexico and the annual death rates by age and sex. Methods: The official National Database of Mortality was used to establish date and cause of deaths (Instituto Nacional de Estadística y Geografía [INEGI] from 2000 to 2010 in Mexico. Age-standardized rates were calculated by direct method; annual rates of death by sex in two age-groups (45-64 years old and 65 or more years old) were calculated. The codes of the International Statistical Classification of Diseases and Related Health Problems 10th Revision (CIE-10) J60-J80, J82-J84 y J99.1 were analyzed. Results: Of 5,420,059 deaths registered, 22,600 were diagnosed as death of an interstitial lung disease between 2000 and 2010 (0.4%). The CIE-10 code with a higher percentage of deaths was J84: "other pulmonary interstitial diseases" with 80.2% (18,127/22,600). This code includes the rheumatic diseases and autoimmune diseases that exhibit a lung interstitial disease. The age-standardized mortality rates by lung interstitial diseases shown an increasing trend during 2000-2010, but men exhibited higher rates than women; the description of annual mortality shown that the rates specific by age and sex were increasing in both sex but higher in male than female. The age group more affected was of 65 or more years old. Conclusions: This article shows the relevance of interstitial lung diseases as a death cause in Mexico. In the next years will be required additional resources to medical care in these diseases.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Incidence and prevalence of idiopathic pulmonary fibrosis.

          Idiopathic pulmonary fibrosis is a chronic interstitial lung disease of unknown etiology; its epidemiology in the United States has not been well characterized. To estimate the annual incidence and prevalence of idiopathic pulmonary fibrosis in the United States. Retrospective cohort design utilizing a large health care claims database spanning the period January 1996 through December 2000. Persons with idiopathic pulmonary fibrosis were identified based on diagnosis and procedure codes. Using broad case-finding criteria, prevalence was estimated to range from 4.0 per 100,000 persons aged 18 to 34 yr to 227.2 per 100,000 among those 75 yr or older; annual incidence was estimated to range from 1.2 to 76.4 per 100,000. Using narrow case-finding criteria, prevalence ranged from 0.8 to 64.7 per 100,000 persons; comparable figures for incidence were 0.4 to 27.1 per 100,000 persons. Extrapolating these rates to the overall United States' population, prevalence was estimated to be 42.7 per 100,000 (incidence, 16.3 per 100,000) using broad criteria; with narrow criteria, prevalence was estimated to be 14.0 per 100,000 (incidence, 6.8 per 100,000). Our results suggest that idiopathic pulmonary fibrosis is probably more common in the United States than previously reported.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis.

            We conducted a multicenter case-control study of clinically and histologically diagnosed idiopathic pulmonary fibrosis (IPF), a chronic diffuse interstitial lung disease of unknown cause. The study included 248 cases, and 491 control subjects identified through random-digit dialing, matched to cases in sex, age, and geographic region. Telephone interviews were conducted with both cases and controls to collect information on potential risk factors for IPF, including smoking and household, occupational, and environmental exposures. Pulmonary function tests, X-rays, computed tomographic (CT) scans of the chest, and lung biopsy reports were submitted by referring centers to support the diagnoses. An a priori hypothesis that smoking is associated with IPF was examined with conditional logistic regression analyses. More cases (72%) than control subjects (63%) had a history of ever smoking. The odds ratio (OR) for ever smoking was 1.6 (95% CI: 1.1 to 2.4). Risk was significantly elevated for former smokers (OR = 1.9; 95% CI: 1.3 to 2.9) and for smokers with 21 to 40 pack-yr (OR = 2.3; 95% CI: 1.3 to 3.8). A history of smoking is associated with an increased risk for the development of IPF. Although there was no clear exposure-response pattern with cumulative consumption of cigarettes, there was a trend for time since cessation of smoking, with the highest risk for those who had most recently quit.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study.

              The prevalence of interstitial lung disease (ILD) in RA is ∼5%. Previous work identified increasing age, active articular disease and articular damage as risk factors for RA-associated ILD (RA-ILD). The roles of high-resolution CT (HRCT) and lung function testing in defining the nature and extent of pulmonary involvement have recently been explored. This study is the first to examine predictive and prognostic factors for the development of RA-ILD and to report on the physiological and radiological characteristics of the condition from a large multicentre UK network.
                Bookmark

                Author and article information

                Journal
                nct
                Neumología y cirugía de tórax
                Neumol. cir. torax
                Sociedad Mexicana de Neumología y Cirugía de Tórax; Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas; Sociedad Cubana de Neumología; Sociedad Paraguaya de Neumología; Sociedad Boliviana de Neumología. (México, DF, Mexico )
                0028-3746
                September 2014
                : 73
                : 3
                : 179-184
                Affiliations
                [01] Ciudad de México orgnameInstituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas
                Article
                S0028-37462014000300004 S0028-3746(14)07300300004
                c54d7879-5c73-4442-972d-ef51a28b8c38

                This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

                History
                : 26 September 2014
                : 19 August 2014
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 29, Pages: 6
                Product

                SciELO Mexico

                Categories
                Trabajos originales

                México,Interstitial lung disease,Mexico,mortality,mortalidad,Enfermedades intersticiales

                Comments

                Comment on this article